HSBC Holdings’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-878,914
Closed -$14.7M 3253
2022
Q4
$14.7M Buy
878,914
+98,628
+13% +$1.67M 0.02% 773
2022
Q3
$13.4M Buy
780,286
+740,390
+1,856% +$11.6M 0.02% 720
2022
Q2
$317K Sell
39,896
-3,893
-9% -$33.4K ﹤0.01% 2605
2022
Q1
$484K Buy
+43,789
New +$490K ﹤0.01% 2443
2021
Q3
Sell
-6,137
Closed -$203K 3220
2021
Q2
$203K Buy
+6,137
New +$232K ﹤0.01% 2752
2021
Q1
Sell
-5,347
Closed -$233K 3242
2020
Q4
$233K Buy
+5,347
New +$183K ﹤0.01% 2724

HSBC Holdings's ONEM Position: Q1 2023 in Review

HSBC Holdings sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 878,914 shares — an estimated $14.7M sold.

HSBC Holdings first reported a position in ONEM in Q4 2020 and held it in 6 quarters. The position peaked at $14.7M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • HSBC Holdings reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 878,914 1Life Healthcare shares in Q1 2023, an estimated $14.7M.
  • HSBC Holdings first reported a position in 1Life Healthcare in Q4 2020 and held it in 6 quarters.
  • HSBC Holdings's 1Life Healthcare position peaked at $14.7M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.